QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BBIO

QT63BridgeBio Pharma, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
66.27
-1.12-1.66%
OverviewShort InterestFilings
BBIOQT63BridgeBio Pharma, Inc.·NASDAQ
OverviewShort InterestFilings
66.27-1.66%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-3.75
Insider Own29.15%
Shs Outstand195.86M
Perf Week-1.89%
Market Cap13.20BForward P/E122.68EPS next Y0.54Insider Trans-0.05%Shs Float-Perf Month0.41%
Enterprise Value15.70BPEG1.98EPS next Q-0.63Inst Own-Short Float-Perf Quarter-5.42%
Income-729908725.00P/S22.76EPS this Y42.20%Inst Trans-Short Ratio-Perf Half Y-12.45%
Sales579.96MP/B-EPS next Y124.92%ROA-52.95%Short Interest-Perf YTD-13.36%
Book/sh-11.59P/C-EPS next 5Y-ROE36.00%52W High84.94 -21.98%Perf Year65.39%
Cash/sh4.80P/FCF-EPS past 3/5Y-ROIC-57.94%52W Low39.65 67.14%Perf 3Y-
Dividend Est.-EV/EBITDA-25.79Sales past 3/5Y86.01% 128.84%Gross Margin93.78%Volatility2.18% 2.56%Perf 5Y-
Dividend TTM-EV/Sales27.08EPS Y/Y TTM-29.86%Oper. Margin-98.40%ATR (14)2.71Perf 10Y-
Dividend Ex-Date-Quick Ratio1.40Sales Y/Y TTM161.71%Profit Margin-125.17%RSI (14)45.42Recom2.18
Dividend Gr. 3/5Y-Current Ratio1.44EPS Q/Q4.55%SMA20-1.31%Beta1.12Target Price104.60
Payout0.00%Debt/Eq-1.49Sales Q/Q66.67%SMA50-4.87%Rel Volume1.35Prev Close67.39
Employees725LT Debt/Eq-1.31EarningsAug 04SMA200-1.89%Avg Volume2.82MPrice66.27
IPO DateJun 27, 2019Option/ShortYes / YesEPS/Sales Surpr.-23.75% 9.55%Net Debt/EBITDA-4.11Volume3,815,335Change-1.66%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-16-26ReiteratedMizuho Securities$53 → $96
Jun-03-26InitiatedCanaccordBuy$104
May-28-26ReiteratedMorgan StanleyOverweight$96 → $98
May-26-26DowngradeRaymond JamesOutperform → Market Perform
May-11-26ReiteratedH.C. WainwrightBuy$100 → $110
May-08-26ReiteratedEvercore ISI$125 → $130
May-08-26ReiteratedBernstein$100 → $114
Apr-29-26ReiteratedTruist Financial$95 → $102
Apr-08-26InitiatedRBC CapitalOutperform$100
Mar-12-26ReiteratedLeerink PartnersOutperform$86 → $98
Latest News
Jun-16-26
Jun-16-2608:20AM
Mizuho Maintains Outperform on BridgeBio Pharma, Lowers Price Target to $96Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue581502222
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A36284
Gross Profit544474218
Selling, General and Administrative Excl. Other613555289
Research and Development493478506
Other Operating Expense81016
Operating Income-570-569-593
Interest Expense1155399
Unusual Expense
———
Non-Operating Income (Expense)48113-150
Net Income Before Taxes-732-735-542
Income Taxes011
Consolidated Net Income-726-729-536
Net Income From Continuing Operations-733-736-543
Net Income-726-729-536
EPS (Recurring)-3.75-3.79-2.88
EPS (Basic, Before Extraordinaries)-3.75-3.79-2.88
EPS (Diluted)-3.75-3.79-2.88
EBITDA-609-673-437
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio22.2430.02—
Gross Margin93.6394.4298.20
Operating Margin-98.11-113.35-267.12
Net Margin-124.96-145.22-241.44
Shares Outstanding195197186
Market Capitalization12,92315,069—
Operating Lease Expense
———
Insider Trading Volume
$70.49$61.85$53.20$44.56$35.92● Close Price0.00M39.70M79.40M119.10M158.80MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cook Jennifer E.DirectorJun 15 '26Sale66.6290,2406,012,1576,589Jun 17 12:00 AM
Cook Jennifer E.DirectorJun 15 '26Option Exercise10.16166,1761,689,15896,829Jun 17 12:00 AM
Kumar NeilChief Executive OfficerJun 05 '26Sale67.8840,0002,715,076515,686Jun 08 12:00 AM
Kumar NeilChief Executive OfficerJun 04 '26Sale67.4640,0002,698,210535,686Jun 08 12:00 AM
Kumar NeilChief Executive OfficerMay 21 '26Sale69.4426,1031,812,522243,327May 26 12:00 AM
Trimarchi ThomasPresident and CFOMay 18 '26Sale65.0813,651888,419359,194May 19 12:00 AM
Kumar NeilChief Executive OfficerMay 16 '26Option Exercise0.00142,4300305,666May 19 12:00 AM
Scott Randal W.DirectorMay 15 '26Sale67.1510,000671,45511,589May 19 12:00 AM
Scott Randal W.DirectorMay 15 '26Option Exercise16.7520,000335,00021,589May 19 12:00 AM
Kumar NeilChief Executive OfficerMay 08 '26Sale66.9140,0002,676,300555,686May 11 12:00 AM
Kumar NeilChief Executive OfficerMay 07 '26Sale67.9040,0002,715,942575,686May 11 12:00 AM
Apuli MaricelChief Accounting OfficerApr 30 '26Sale71.582,000143,160134,115May 04 12:00 AM
Kumar NeilChief Executive OfficerApr 10 '26Sale74.6040,0002,984,172595,686Apr 13 12:00 AM
Kumar NeilChief Executive OfficerApr 09 '26Sale74.6240,0002,984,608615,686Apr 13 12:00 AM
Kumar NeilChief Executive OfficerMar 13 '26Sale68.8040,0002,751,803635,686Mar 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR